Update on endemic nephropathies

Current Opinion in Nephrology and Hypertension

Volumn 23, Issue 3, 2014, Pages 232-238

  Wernerson, Annika ^a   Wijkström, Julia ^a   Elinder, Carl Gustaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Balkan endemic nephropathy; chronic kidney disease; endemic nephropathy; kidney disease; Mesoamerican nephropathy

Indexed keywords

ARISTOLOCHIC ACID; CADMIUM; LEAD; MERCURY; OCHRATOXIN;

CHINESE HERB NEPHROPATHY; CHRONIC KIDNEY DISEASE; DEHYDRATION; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; HUMAN; INDIA; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY ISCHEMIA; MESOAMERICAN NEPHROPATHY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; SRI LANKA; TUBULAR DYSFUNCTION; ASIA; BALKAN NEPHROPATHY; CENTRAL AMERICA; EPIDEMIOLOGY; EUROPE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR;

ASIA; BALKAN NEPHROPATHY; CENTRAL AMERICA; ENDEMIC DISEASES; EUROPE; HUMANS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84898448304     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/01.mnh.0000444911.32794.e7     Document Type: Review

References (43)

1. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375:1296-1309.
2. Jha V, Garcia-Garcia G, Iseki K. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260-272.
3. Spuhler O, Zollinger HO. Die chronisch-interstitielle Nephritis. Zeit Klin Med 1953; 151:1-50.
4. Elseviers MM, De Broe M. Analgesics and 5-aminosalicylic acid. In: De Broe ME, Porter GA, editors. Clinical nephrotoxins renal injury from drugs and chemicals, 3rd ed. New York, NY: Springer; 2008. pp. 399- 417.
5. Ferluga D, Hvala A, Vizjak A, et al. Renal function, protein excretion, and pathology of Balkan endemic nephropathy. III. Light and electron microscopic studies. Kidney Int Suppl 1991; 34:S57-S67.
6. Gokmen MR, Cosyns JP, Arlt VM, et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med 2013; 158:469-477.
7. Grollman AP, Jelakovic B. Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia. J Am Soc Nephrol 2007; 18:2817-2823.
8. Voice TC, Long DT, Radovanovic Z, et al. Critical evaluation of environmental exposure agents suspected in the etiology of Balkan endemic nephropathy. Int J Occup Environ Health 2006; 12:369-376.
9. Marin S, Ramos AJ, Cano-Sancho G, Sanchis V. Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem Toxicol 2013; 60:218-237.
10. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341:387-391.
11. Jelakovic B, Karanovic S, Vukovic-Lela I, et al. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 2012; 81:559-567.
12. Chen CH, Dickman KG, Moriya M, et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 2012; 109:8241-8246.
13. Batuman E. Poisoned land. The New Yorker 2013; 42-47.
14. Grollman AP. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease. Environ Mol Mutagen 2013; 54:1-7.
15. Baudoux TE, Pozdzik AA, Arlt VM, et al. Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy. Kidney Int 2012; 82:1105-1113.
16. OBrien E, Dietrich DR. Ochratoxin A: the continuing enigma. Crit Rev Toxicol 2005; 35:33-60.
17. Stoev SD, Dutton MF, Njobeh PB, et al. Mycotoxic nephropathy in Bulgarian pigs and chickens: complex aetiology and similarity to Balkan endemic nephropathy. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2010; 27:72-88.
18. Stoev SD, Hald B, Mantle PG. Porcine nephropathy in Bulgaria: a progressive syndrome of complex or uncertain (mycotoxin) aetiology. Vet Rec 1998; 142:190-194.
19. Hmaissia Khlifa K, Ghali R, Mazigh C, et al. Ochratoxin A levels in human serum and foods from nephropathy patients in Tunisia: where are you now? Exp Toxicol Pathol 2012; 64:509-512.
20. Barregard L, Elinder CG. Renal effects from exposure to metals. In: Nordberg GF, Fowler BA, Nordberg M, editors. Handbook on the toxicology of metals, 4th ed. Amsterdam: Academic Press/Elsevier; 2014.
21. Evans M, Elinder CG. Chronic renal failure from lead: myth or evidence-based fact? Kidney Int 2011; 79:272-279.
22. Friberg L. Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning; a clinical and experimental study. Acta Med Scand 1950; 240 (Suppl. 1):1-124.
23. Elinder C-G. Epidemiology and toxicity of cadmium. UpToDate [Internet]. Waltham, MA: UpToDate; 2013.
24. Bonnell JA, Ross JH, King E. Renal lesions in experimental cadmium poisoning. Br J Ind Med 1960; 17:69-80.
25. Elinder C-G. Epidemiology and toxicity of mercury. 2013. UpToDate [Internet]. Waltham, MA: UpToDate; 2013.
26. ANZDaTR. Trends in kidney disease over time. 2013.
27. Hoy WE, Samuel T, Mott SA, et al. Renal biopsy findings among indigenous Australians: a nationwide review. Kidney Int 2012; 82:1321-1331.
28. Ramirez-Rubio O, McClean MD, Amador JJ, Brooks DR. An epidemic of chronic kidney disease in Central America: an overview. J Epidemiol Community Health 2013; 67:1-3.
29. Torres C, Aragon A, Gonzalez M, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis 2010; 55:485-496.
30. Peraza S, Wesseling C, Aragon A, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis 2012; 59:531-540.
31. Weiner DE, McClean MD, Kaufman JS, Brooks DR. The Central American epidemic of CKD. Clin J Am Soc Nephrol 2013; 8:504-511.
32. Wijkstrom J, Leiva R, Elinder CG, et al. Clinical and pathological characterization of mesoamerican nephropathy: a new kidney disease in Central America. Am J Kidney Dis 2013; 67:908-918.
33. Wesseling C, Crowe J, Hogstedt C, et al. Resolving the enigma of the mesoamerican nephropathy: a research workshop summary. Am J Kidney Dis 2014; 63:396-404.
34. Wesseling C, Crowe J, Hogstedt C, et al. Report from the First International Research Workshop on MeN. Costa Rica: Program on Work, Environment and Health in Central America (SALTRA) and Central American Institute for Studies on Toxic Substances (IRET) Universidad Nacional (UNA), Costa Rica; 239 pp
35. Johnson RJ, Sanchez-Lozada LG. Chronic kidney disease: mesoamerican nephropathy - new clues to the cause. Nat Rev Nephrol 2013; 9:560-561.
36. Crowe J, Wesseling C, Solano BR, et al. Heat exposure in sugarcane harvesters in Costa Rica. Am J Ind Med 2013; 56:1157-1164.
37. Ramirez-Rubio O, Brooks DR, Amador JJ, et al. Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health 2013; 13:350-358.
38. Roncal Jimenez CA, Ishimoto T, Lanaspa MA, et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int 2013. doi: 10.1038/ ki.2013.492. [Epub ahead of print]
39. Nanayakkara S, Senevirathna ST, Karunaratne U, et al. Evidence of tubular damage in the very early stage of chronic kidney disease of uncertain etiology in the North Central Province of Sri Lanka: a cross-sectional study. Environ Health Prev Med 2012; 17:109-117.
40. Nanayakkara S, Komiya T, Ratnatunga N, et al. Tubulointerstitial damage as the major pathological lesion in endemic chronic kidney disease among farmers in North Central Province of Sri Lanka. Environ Health Prev Med 2012; 17:213-221.
41. Jayatilake N, Mendis S, Maheepala P, et al. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC Nephrol 2013; 14:180-192.
42. Rajapurkar MM, John GT, Kirpalani AL, et al. What do we know about chronic kidney disease in India: first report of the Indian CKD Registry. BMC Nephrol 2012; 13:10-17.
43. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58:295-300.